Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells

Abstract

A variety of protocols have been developed that demonstrate the capability to differentiate human pluripotent stem cells (hPSCs) into kidney structures. Our goal was to develop a high-efficiency protocol to generate nephron progenitor cells (NPCs) and kidney organoids to facilitate applications for tissue engineering, disease modeling and chemical screening. Here, we describe a detailed protocol resulting in high-efficiency production (80–90%) of NPCs from hPSCs within 9 d of differentiation. Kidney organoids were generated from NPCs within 12 d with high reproducibility using 96-well plates suitable for chemical screening. The protocol requires skills for culturing hPSCs and careful attention to morphological changes indicative of differentiation. This kidney organoid system provides a platform for studies of human kidney development, modeling of kidney diseases, nephrotoxicity and kidney regeneration. The system provides a model for in vitro study of kidney intracellular and intercompartmental interactions using differentiated human cells in an appropriate nephron and stromal context.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The differentiation protocols for deriving kidney organoids from hPSCs.
Figure 2: Morphological changes of hPSCs at each step of differentiation.
Figure 3: Immunostaining for NPCs and nephrons.
Figure 4: Nephrotoxicity assay.

Similar content being viewed by others

References

  1. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).

    Article  CAS  Google Scholar 

  2. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

    Article  CAS  Google Scholar 

  3. Takasato, M. et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat. Cell Biol. 16, 118–126 (2014).

    Article  CAS  Google Scholar 

  4. Lam, A.Q. et al. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J. Am. Soc. Nephrol. 25, 1211–1225 (2014).

    Article  CAS  Google Scholar 

  5. Taguchi, A. et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14, 53–67 (2014).

    Article  CAS  Google Scholar 

  6. Vigneau, C. et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J. Am. Soc. Nephrol. 18, 1709–1720 (2007).

    Article  CAS  Google Scholar 

  7. Bruce, S.J. et al. In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation 75, 337–349 (2007).

    Article  CAS  Google Scholar 

  8. Morizane, R., Monkawa, T. & Itoh, H. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro. Biochem. Biophys. Res. Commun. 390, 1334–1339 (2009).

    Article  CAS  Google Scholar 

  9. Narayanan, K. et al. Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney Int. 83, 593–603 (2013).

    Article  CAS  Google Scholar 

  10. Morizane, R. et al. Kidney specific protein-positive cells derived from embryonic stem cells reproduce tubular structures in vitro and differentiate into renal tubular cells. PLoS One 8, e64843 (2013).

    Article  CAS  Google Scholar 

  11. Mae, S. et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat. Commun. 4, 1367 (2013).

    Article  Google Scholar 

  12. Xia, Y. et al. The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor-like cells. Nat. Protoc. 9, 2693–2704 (2014).

    Article  Google Scholar 

  13. Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564–568 (2015).

    Article  CAS  Google Scholar 

  14. Freedman, B.S. et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat. Commun. 6, 8715 (2015).

    Article  CAS  Google Scholar 

  15. Morizane, R. et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193–1200 (2015).

    Article  CAS  Google Scholar 

  16. Iimura, T. & Pourquie, O. Collinear activation of Hoxb genes during gastrulation is linked to mesoderm cell ingression. Nature 442, 568–571 (2006).

    Article  CAS  Google Scholar 

  17. Deschamps, J. & van Nes, J. Developmental regulation of the Hox genes during axial morphogenesis in the mouse. Development 132, 2931–2942 (2005).

    Article  CAS  Google Scholar 

  18. Lengerke, C. et al. BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell 2, 72–82 (2008).

    Article  CAS  Google Scholar 

  19. Hobbs, R.F., Song, H., Huso, D.L., Sundel, M.H. & Sgouros, G. A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry. Phys. Med. Biol. 57, 4403–4424 (2012).

    Article  CAS  Google Scholar 

  20. Devuyst, O. et al. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet 383, 1844–1859 (2014).

    Article  Google Scholar 

  21. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).

    Article  CAS  Google Scholar 

  22. Sterneckert, J.L., Reinhardt, P. & Scholer, H.R. Investigating human disease using stem cell models. Nat. Rev. Genet. 15, 625–639 (2014).

    Article  CAS  Google Scholar 

  23. Taguchi, A. & Nishinakamura, R. Nephron reconstitution from pluripotent stem cells. Kidney Int. 87, 894–900 (2015).

    Article  CAS  Google Scholar 

  24. Osafune, K. et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26, 313–315 (2008).

    Article  CAS  Google Scholar 

  25. Deen, P.M. et al. Assignment of the human gene for the water channel of renal collecting duct Aquaporin 2 (AQP2) to chromosome 12 region q12-->q13. Cytogenet. Cell Genet. 66, 260–262 (1994).

    Article  CAS  Google Scholar 

  26. Humphreys, B.D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85–97 (2010).

    Article  CAS  Google Scholar 

  27. Samulowitz, U. et al. Human endomucin: distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope. Am. J. Pathol. 160, 1669–1681 (2002).

    Article  CAS  Google Scholar 

  28. Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 4, 3594 (2014).

    Article  Google Scholar 

  29. Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681–686 (2007).

    Article  CAS  Google Scholar 

  30. Bennett, C.N. et al. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277, 30998–31004 (2002).

    Article  CAS  Google Scholar 

  31. Vaidya, V.S., Ramirez, V., Ichimura, T., Bobadilla, N.A. & Bonventre, J.V. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal Physiol. 290, F517–529 (2006).

    Article  CAS  Google Scholar 

  32. Vaidya, V.S. et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat. Biotechnol. 28, 478–485 (2010).

    Article  CAS  Google Scholar 

  33. Freedman, B.S. et al. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J. Am. Soc. Nephrol. 24, 1571–1586 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank N. Gupta for providing the immunohistochemistry images of kidney organoids in Supplementary Figure 1. This study was supported by National Institutes of Health grants R37 DK039773 and R01 DK072381 (to J.V.B.), a Grant-in-Aid for a Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Research Abroad (to R.M.), a ReproCell Stem Cell Research grant (to R.M.), a Brigham and Women's Hospital Research Excellence Award (to R.M.), a Brigham and Women's Hospital Faculty Career Development Award (to R.M.) and a Harvard Stem Cell Institute Seed grant (to R.M.).

Author information

Authors and Affiliations

Authors

Contributions

R.M. and J.V.B. formulated the strategy for this study. R.M. designed and performed experiments. R.M. and J.V.B. wrote the manuscript. J.V.B. helped to design the experiments and to interpret the results.

Corresponding author

Correspondence to Ryuji Morizane.

Ethics declarations

Competing interests

J.V.B. is a co-inventor on KIM-1 patents that have been licensed by Partners Healthcare to several companies. He has received royalty income from Partners Healthcare. J.V.B. and R.M. are co-inventors on patents (PCT/US16/52350) on organoid technologies that are assigned to Partners Healthcare. J.V.B. or his family has received income for consulting from companies interested in biomarkers: Sekisui, Millennium, Johnson & Johnson and Novartis. J.V.B. is a consultant to Goldfinch Bio. J.V.B. owns equity in Goldfinch Bio.

Integrated supplementary information

Supplementary Figure 1 Immunostaining for interstitial cells and connecting tubules and collecting ducts.

(a) Immunostaining for PDGFRb (platelet derived growth factor receptor beta) and endomucin in 3D kidney organoids. PDGFRβ was assessed by immunohistochemistry in 3D kidney organoids on day 65. Endomucin was evaluated by whole mount staining in 3D kidney organoids on day 24. Arrows indicate endomucin+ endothelia in a glomerular structure. (b) Immunohistochemistry for α-SMA (smooth muscle alpha-actin) in 3D kidney organoids on day 65. There was a very small population of α-SMA+ interstitial cells in kidney organoids. (c) Immunohistochemistry for aquaporin-2 (AQP2) in CDH1+ tubule in 3D kidney organoids on day 35. AQP2+ tubules were found in only CDH1+ tubules, indicating presence of connecting tubules/collecting ducts in kidney organoids. Scale bars: 50 μm.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1 (PDF 225 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morizane, R., Bonventre, J. Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells. Nat Protoc 12, 195–207 (2017). https://doi.org/10.1038/nprot.2016.170

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2016.170

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing